Axel Seher

1.4k total citations
45 papers, 1.0k citations indexed

About

Axel Seher is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Axel Seher has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Axel Seher's work include Cell death mechanisms and regulation (9 papers), RNA Interference and Gene Delivery (8 papers) and TGF-β signaling in diseases (8 papers). Axel Seher is often cited by papers focused on Cell death mechanisms and regulation (9 papers), RNA Interference and Gene Delivery (8 papers) and TGF-β signaling in diseases (8 papers). Axel Seher collaborates with scholars based in Germany, Egypt and United States. Axel Seher's co-authors include Joachim Nickel, Walter Sebald, Thomas D. Mueller, Alexander Kotzsch, Stefan Hartmann, Urs Müller‐Richter, Roman C. Brands, Harald Wajant, Christian Linz and Alexander Kübler and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Axel Seher

45 papers receiving 1.0k citations

Peers

Axel Seher

ONCOL

IMMUN

Wenshu Wu China

Cédric Zeltz Norway

Peihong Su China

Huiyu Yao China

Peilong Lai China

Taocong Jin United States

Karim Shamsasenjan Iran

Graham Rushton United Kingdom

Richard J. Bauer Germany

Wenshu Wu China

Axel Seher

757 ×1.1

174 ×0.7

213 ×1.1

ONCOL

118 ×0.7

IMMUN

94 ×0.8

Citations per year, relative to Axel Seher Axel Seher (= 1×) peers Wenshu Wu

Countries citing papers authored by Axel Seher

Since Specialization

Citations

This map shows the geographic impact of Axel Seher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Seher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Seher more than expected).

Fields of papers citing papers by Axel Seher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Seher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Seher. The network helps show where Axel Seher may publish in the future.

Co-authorship network of co-authors of Axel Seher

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Seher. A scholar is included among the top collaborators of Axel Seher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Seher. Axel Seher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brands, Roman C., Stefan Hartmann, Axel Seher, et al.. (2020). Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro. Journal of Cranio-Maxillofacial Surgery. 48(7). 685–693. 4 indexed citations

Seher, Axel, Christian Linz, Stefan Hartmann, et al.. (2019). Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro. Journal of Cranio-Maxillofacial Surgery. 47(10). 1589–1599. 14 indexed citations

Youssef, Almoatazbellah, Axel Seher, Stefan Hartmann, et al.. (2019). A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting – An in vitro study. Journal of Cranio-Maxillofacial Surgery. 47(4). 695–703. 22 indexed citations

Youssef, Almoatazbellah, Axel Seher, Gernot Hochleitner, et al.. (2019). Medical-grade polycaprolactone scaffolds made by melt electrospinning writing for oral bone regeneration – a pilot study in vitro. BMC Oral Health. 19(1). 28–28. 51 indexed citations

Hartmann, Stefan, Roman C. Brands, Axel Seher, et al.. (2017). MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer. Clinical Oral Investigations. 22(3). 1477–1486. 15 indexed citations

Brands, Roman C., et al.. (2017). Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro. Oncology Reports. 38(3). 1877–1885. 23 indexed citations

El‐Mesery, Mohamed, Alexander Kübler, Urs Müller‐Richter, et al.. (2017). The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent. PLoS ONE. 12(10). e0185720–e0185720. 8 indexed citations

Seher, Axel, Thorsten Stühmer, Urs Müller‐Richter, et al.. (2017). Utilizing BMP-2 muteins for treatment of multiple myeloma. PLoS ONE. 12(5). e0174884–e0174884. 8 indexed citations

Brands, Roman C., Stefan Hartmann, Axel Seher, et al.. (2016). Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines. Clinical Oral Investigations. 20(9). 2325–2332. 15 indexed citations

10.

Brands, Roman C., Urs Müller‐Richter, Axel Seher, et al.. (2016). Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin. Molecular Medicine Reports. 13(3). 2338–2344. 14 indexed citations

11.

Brands, Roman C., Stefan Hartmann, Harald Ebhardt, et al.. (2016). The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa. Clinical Oral Investigations. 21(5). 1631–1637. 9 indexed citations

12.

Hartmann, Stefan, Till Meyer, Roman C. Brands, et al.. (2015). MAGE-A expression clusters and antineoplastic treatment in head and neck cancer. International Journal of Molecular Medicine. 35(6). 1675–1682. 9 indexed citations

13.

Seher, Axel, et al.. (2014). TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK. Frontiers in Immunology. 5. 63–63. 11 indexed citations

14.

Hartmann, Stefan, Axel Seher, Roman C. Brands, et al.. (2014). Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cells. Journal of Cranio-Maxillofacial Surgery. 42(7). 1322–1328. 15 indexed citations

15.

Salzmann, Steffen, et al.. (2013). Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity. Journal of Biological Chemistry. 288(19). 13455–13466. 36 indexed citations

16.

Fick, Andrea, et al.. (2011). Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14). Journal of Biological Chemistry. 287(1). 484–495. 44 indexed citations

17.

Seher, Axel, et al.. (2009). Receptor oligomerization and beyond: a case study in bone morphogenetic proteins. BMC Biology. 7(1). 59–59. 107 indexed citations

18.

Kunzmann, Steffen, Axel Seher, Boris W. Kramer, et al.. (2008). Connective Tissue Growth Factor Does Not Affect Transforming Growth Factor-Beta 1-Induced Smad3 Phosphorylation and T Lymphocyte Proliferation Inhibition. International Archives of Allergy and Immunology. 147(2). 152–160. 7 indexed citations

19.

Kotzsch, Alexander, Joachim Nickel, Axel Seher, et al.. (2007). Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome. Journal of Biological Chemistry. 283(9). 5876–5887. 50 indexed citations

20.

Nickel, Joachim, et al.. (2007). Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand. FEBS Journal. 275(1). 172–183. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact